• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS CREJ2 CREATININE JAFFÉ GEN.2; ALKALINE PICRATE, COLORIMETRY, CREATININE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS CREJ2 CREATININE JAFFÉ GEN.2; ALKALINE PICRATE, COLORIMETRY, CREATININE Back to Search Results
Model Number CREAJ
Device Problem Non Reproducible Results (4029)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 05/20/2022
Event Type  malfunction  
Event Description
There was an allegation of questionable crej2 creatinine jaffé gen.2 results for two samples from one patient.The customer questioned if the patient's medications/treatments could have affected the results.Sample 1 was drawn at 01:56 pm and the results were 6.16 mg/dl, 6.25 mg/dl, and 6.59 mg/dl.Sample 2 was drawn at 5:12 pm and the results were 0.27 mg/dl and 0.31 mg/dl.The questionable results were not reported outside of the laboratory.The customer used cobas 6000 c501 module serial number (b)(4).
 
Manufacturer Narrative
The investigation is ongoing.
 
Manufacturer Narrative
The analyzer alarm trace contained several abnormal probe sucking alarms on the date of the event.This is usually an indicator of a pre-analytical handling issue.The provided data for calibration and quality control were within the specification.Therefore a general reagent and/or system-related issue could be excluded.The investigation did not identify a product problem.The cause of the event could not be determined as no sample material was available for further investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CREJ2 CREATININE JAFFÉ GEN.2
Type of Device
ALKALINE PICRATE, COLORIMETRY, CREATININE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key14735813
MDR Text Key301990120
Report Number1823260-2022-01777
Device Sequence Number1
Product Code CGX
UDI-Device Identifier04015630922284
UDI-Public04015630922284
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
K941837
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 08/04/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2023
Device Model NumberCREAJ
Device Catalogue Number04810716190
Device Lot Number60357801
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/26/2022
Initial Date FDA Received06/17/2022
Supplement Dates Manufacturer Received07/11/2022
Supplement Dates FDA Received08/04/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
BACLOFEN; DEXAMETHASONE; DIAZEPAM; DIPYRONE; FUROSEMIDE; METHADONE; OMEPRAZOLE; ONDANSETRON; PARACETAMOL; SPIRONOLACTONE; VALPROIC ACID
Patient Age5 YR
Patient SexFemale
-
-